Anbex Awarded Bid from Hong Kong’s Department of Health
April 4, 2024
St. George-based Anbex has been awarded a bid from Hong Kong’s Department of Health for the supply of 187,040, 130mg IOSAT tablets. Anbex had previously won a similar-sized award from Hong Kong in 2021 on the supply of their potassium iodide tablets. Anbex is currently bidding on the supply of IOSAT tablets to Mexico, Argentina, Brazil, and Saudi Arabia. Anbex contracts with St. George-based Deseret Labs to manufacture the tablets.
For more information, visit anbex.com.
Recent News
- Collaboration with Quest Diagnostics to expand kidneyintelX.dkd TM testing in the United States
- Utah Business Innovation Awards Summit Recap
- Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy
- Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base
- Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
- U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam for Pediatric Patients with Tourette Syndrome
